Hepatitis B vaccine: Completed Phase IIb/III enrollment

Abivax completed enrollment of 266 patients with hepatitis B e antigen (HBeAg)-negative active chronic HBV infection in an open-label, international Phase IIb/III trial comparing 10 doses of subcutane...